Opus Genetics's total assets for Q4 2024 were $36.86M, a decrease of -8.73% from the previous quarter. IRD total liabilities were $30.14M for the fiscal quarter, a 394.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.